A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus
Clinical trial NCT02609789 · COMPLETED
Trial details
- NCT number
- NCT02609789
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-09-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.